Gturbo

Gturbo

ICO Ended
12,621 Views
GTurbo provides opportunity for robust investment in a well-established production of gas turbines. Purchase of the GTurbo derivative is a value-enhancing investment in real sector that implies clear and reliable scheme of buyout GTR tokens. Investing in GTurbo in the early stages will allow the participants to get profit of up to 300%.
5.5
TOTAL SCORE
7.7
ICO PROFILE

(weight: 45%)

5
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Pre-sale Time: 04 Nov 2018 - 18 Nov 2018
ICO Time: 26 Nov 2018 - 26 Dec 2018
Whitelist/KYC: Whitelist + KYC
Country: Russia
Token info
Ticker: GTR
Platform: Ethereum
Token Type: ERC20
Available for sale: 416,000,000 GTR (92%)
Financial
ICO Price: 1 GTR = 0.05 USD
Accepting: BTC, ETH
December 2017
We produce 3 turbines a year.
November, 4 - November, 18, 2018
Pre-ICO.
November, 26 - December, 26, 2018
ICO.
February 2019
Start of manufacture modernization.
June 2019
We produce 10 turbines a year.
June 2021
Buyout price of GTR - 0,2$.
March 2022
Buyout price of GTR - 0,25$.
March 2023
Buyout price of GTR - 0,3$.
March 2024
Buyout price of GTR is $0,4, GTR Token profit is 300%.
Screenshots taken on 19 May 2018
Vitaly Filipov
CEO
Participates in a number of projects
Arhip Agafonov
CTO
Participates in a number of projects
Oleg Prokura
COO
Participates in a number of projects
Grigoriy Tretiak
CRO
Participates in a number of projects
Ivan Andrysiak
CLO
Participates in a number of projects
Evgeniy Bukovshin
CPC
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
Burency
Burency is an advocate for crypto and Blockchain adoption, particularly in the MIDDLE EAST. The platform is designed to address key challenges that prevent widespread adoption within the cryptocurrency and Blockchain ecosystem such as exchange’s lack of liquidity and security, unsustainable mining, unawareness of Blockchain applications to businesses. The Burency Exchange is a regulated exchange platform that addresses key challenges including security, liquidity, fiat to crypto transactions and vise versa, and more. The exchange is one of the world’s fully insured platforms, with coverage provided from LIoyd’s of London through the Nebbex Protocol. The Burency Mining facility answers some of the challenges associated with crypto mining such as mining destruction to environment and excessive mining power expenses by creating a sustainable facility powered by renewable hydropower. Burency provides a streamlined platform for the generation of cryptocurrency via purchased timeshare slots within the mining facilities using the BUY token. Additionally, computational power can also be purchased via the BUY token which governs purchases across the Burency ecosystem. The Burency Blockchain Development Center is dedicated mainly for advising enterprises on Blockchain applications and helping them operate on the blockchain for more efficient operation and business transactions execution. In particular, the center focuses on the creation of smart contracts that enable businesses to trade with entities across geographical and jurisdiction boundaries.
Upcoming
GoRecruit
GoRecruit is an AI recruitment system based on blockchain technology, which offers a new way of evaluating job applicants. The AI system, being a convenient online service, enables making HR decisions based on the analysis of data from social networks and publicly available sources. To select applicants for an interview, one does not need to spend several hours for processing and analyzing the data: one will acquire the detailed information with recommendations immediately after the authorization of a candidate in the GoRecruit system. This approach will make access to vacancies more open, eliminate human error in hiring, as well as reduce the cost of HR service by optimizing routine work.
Upcoming
Svandis
The Svandis ecosystem is driven by a community of users and researchers using powerful Svandis tools, analytics, and indicators for professional traders in need of real-time, actionable data and analyses. The Svandis community drives the rapid collection of verifiable data and information through a tokenized incentive system. The platform within the ecosystem provides leading financial research, analytical and visualisation tools for anyone actively involved in the space: short-term and swing traders, traditional holders, analysts, hedge funds, institutional investors, trading firms, and token sale contributors.
Active
Tempo
Tempo is a French licensed, Paris-based, European-wide anchor for Stellar blockchain payments. The company offers online, offline and digital backed remittances to nearly 100 destination countries with over 300 physical agent locations. Tempo is creating the easiest, fastest and most secure bridge between cash and crypto.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.